docetaxel anhydrous has been researched along with Thymoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Liu, S; Ma, G; Song, W; Wang, H; Yu, G | 1 |
| Hanaoka, J; Hayama, M; Inoue, H; Kanai, O; Kataoka, Y; Kitamura, T; Kobayashi, T; Mio, T; Motoishi, M; Okamoto, K; Okamura, M; Oshio, M; Sawai, S; Tanaka, H | 1 |
| Goto, K; Kirita, K; Matsumoto, S; Niho, S; Ohmatsu, H; Umemura, S; Watanabe, N; Yoh, K | 1 |
| Becherer, A; De Vries, A; Drexel, H; Gasser, K; Gruber-Moesenbacher, U; Lang, A; Muendlein, A; Schuster, A; Winder, T | 1 |
| Achiwa, H; Kato, D; Maeda, H; Niimi, T; Oguri, T; Sato, S; Ueda, R | 1 |
1 review(s) available for docetaxel anhydrous and Thymoma
| Article | Year |
|---|---|
[A case of postoperative thymic carcinoma recurrence that was effectively treated with combination chemotherapy of nedaplatin and docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Recurrence; Taxoids; Thymoma | 2013 |
4 other study(ies) available for docetaxel anhydrous and Thymoma
| Article | Year |
|---|---|
Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report.
Topics: Cardiotoxicity; Disease Progression; Docetaxel; Humans; Immune Checkpoint Inhibitors; Myocarditis; Thymoma; Thymus Neoplasms | 2022 |
Docetaxel for platinum-refractory advanced thymic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Platinum Compounds; Retrospective Studies; Salvage Therapy; Taxoids; Thymoma; Thymus Neoplasms; Treatment Outcome | 2015 |
Advanced inoperable type B3 thymoma: monitoring of a novel therapeutic approach with radio-chemotherapy and sorafenib by FDG-PET and CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Epirubicin; Female; Humans; Image Processing, Computer-Assisted; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiography; Radionuclide Imaging; Taxoids; Thymoma; Thymus Neoplasms; Treatment Outcome | 2010 |
Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cervical Vertebrae; Docetaxel; Female; Humans; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Neoplasms; Taxoids; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2004 |